Research Topics
Genomes and Genes
| Pascal PineauSummaryAffiliation: Institut Pasteur Location: Paris, France Summary: Molecular Epidemiology of primary liver cancer (mutations, oncogenes, tumor suppressors, chromosomes loss, CGH, methylation, expression changes, microRNA, viral variants) Publications
| Collaborators
|
Detail Information
Publications
A t(3;8) chromosomal translocation associated with hepatitis B virus intergration involves the carboxypeptidase N locusP Pineau
Unite de Recombinaison et Expression Genetique, Institut National dela Santé et de la Recherche Médicale INSERM U163, Institut Pasteur, Paris, France
J Virol 70:7280-4. 1996..The present data strongly support a model in which HBV-induced chromosomal rearrangements play a key role during multistep liver oncogenesis...
[A review of cellular senescence: friend or foe of tumorigenesis?]Oliver Bischof
Unité d Organisation Nucléaire et Oncogenèse ONO, INSERM U579, Institut Pasteur, 28, rue du Docteur Roux, 75724 Paris Cedex 15, France
Med Sci (Paris) 25:153-60. 2009..Here, we take a snapshot of the progress in understanding the causes and consequences of cellular senescence in vitro and in vivo...
MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: a case-control analysis in a Moroccan populationSayeh Ezzikouri
Laboratoire de Virologie, Institut Pasteur du Maroc, Casablanca, Morocco
Cancer Detect Prev 32:380-5. 2009..The aim of this study was to investigate whether this functional SNP is associated with an enhanced risk of liver tumorigenesis in Moroccan patients...
The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancerAgustin F Fernandez
Cancer Epigenetics Group, Spanish National Cancer Research Centre CNIO, Madrid E 28029, Spain
Genome Res 19:438-51. 2009..The observed DNA methylation changes have a major functional impact on the biological behavior of the viruses...
Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposurePascal Pineau
Unité d Organisation Nucléaire et Oncogénèse, INSERM U579, Institut Pasteur, 28 rue du Docteur Roux, 75724 Paris Cedex 15, France
Mutat Res 653:6-13. 2008..4% vs. 16.7%, p<0.0001). We suggest that AFB1-associated mutagenesis represents a plausible cause for the higher chromosome instability observed in Chinese HCCs, when compared with European primary liver carcinomas...
Genotype determination in Moroccan hepatitis B chronic carriersSayeh Ezzikouri
Institut Pasteur du Maroc 1, Place Louis Pasteur, 20100 Casablanca, Maroc, Morocco
Infect Genet Evol 8:306-12. 2008..Treatment of chronic hepatitis B is often complicated by the appearance of escape mutants after treatment with nucleoside analogs, especially with genotypes responsible for the more severe form of the disease...
Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan populationSayeh Ezzikouri
Laboratoire de Virologie, Institut Pasteur du Maroc, Casablanca, Morocco
Arch Med Res 39:236-41. 2008..Our objective was to estimate the prevalence of HFE and SERPINA1 (formerly known as alpha1-antitrypsin, AAT) mutations and assess their influence on hepatocellular carcinoma development...
Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patientsSayeh Ezzikouri
Laboratoire de Virologie, Institut Pasteur du Maroc 1, Place Louis Pasteur, 20100, Casablanca, Morocco
Mutat Res 649:1-6. 2008..8% in the control subjects OR, 5.09; 95% CI, 1.76-14.66). Our findings provide further evidence of an association between the Ala-9Val MnSOD polymorphism and HCC occurrence in hepatitis C virus-infected Moroccan patients...
The Pro variant of the p53 codon 72 polymorphism is associated with hepatocellular carcinoma in Moroccan populationSayeh Ezzikouri
Laboratoire de Virologie, Institut Pasteur du Maroc, Casablanca, Morrocco
Hepatol Res 37:748-54. 2007..31-fold increased risk for HCC. Conclusion: These results provide evidence that p53 polymorphism at codon 72 is a modifier of hepatocarcinogenesis, especially in women and HCV-negative subjects...
Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan populationSayeh Ezzikouri
Laboratoire des hépatites virales, Institut Pasteur du Maroc 1, Place Louis Pasteur, 20100 Casablanca, Morocco
Infect Genet Evol 9:877-81. 2009..In addition, we provide genetic evidence for the major difference of HCC risk between men and women. Further mechanistic studies are needed to unravel the underlying molecular mechanisms...
Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphomaEmmanuelle Boulanger
Department of Clinical Immunology, Hopital Saint Louis, Assistance Publique Hopitaux de Paris, Paris, France
Haematologica 94:1170-4. 2009....
Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolismRodolphe Suspène
Institut Pasteur, Molecular Retrovirology Unit, Centre National de la Recherche Scientifique URA3015, 75724 Paris Cedex 15, France
Proc Natl Acad Sci U S A 108:4858-63. 2011..Nonetheless, hyper- and lightly mutated sequences went hand in hand, raising the hypothesis that recurrent low-level mutation by APOBEC3A could catalyze the transition from a healthy to a cancer genome...
First multicenter study for risk factors for hepatocellular carcinoma development in North AfricaOlfa Bahri
Olfa Bahri, Hinda Triki, Laboratory of Clinical Virology, Institut Pasteur of Tunis, Tunis, BP 1002, Tunisia
World J Hepatol 3:24-30. 2011..To assess the role of the major risk factors for hepatocellular carcinoma (HCC) development in the western part of North Africa...
Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigmsC Brechot
INSERM U785, Liver Hepatology centre, Paul Brousse Hospital, University Paris XI, 12, avenue Paul Vaillant Couturier, 94804 Villejuif cedex 15, France
Pathol Biol (Paris) 58:278-87. 2010....
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosisJean Pierre Vartanian
Molecular Retrovirology Unit, Institut Pasteur, Paris, France
PLoS Pathog 6:e1000928. 2010..Although the mutant spectrum resulting from A3 editing is highly deleterious, a very small part, notably the lightly edited genomes, might help the virus evolve and even escape immune responses...
Reprogramming of miRNA networks in cancer and leukemiaStefano Volinia
Data Mining for Analysis of Microarrays, Department of Morphology and Embryology, Universita degli Studi, Ferrara 44100, Italy
Genome Res 20:589-99. 2010..Finally, we experimentally validated the miRNA network with acute lymphocytic leukemia originated in Mir155 transgenic mice. Most of miRNAs deregulated in these transgenic mice were located close to hsa-miR-155 in the cancer network...
miR-221 overexpression contributes to liver tumorigenesisPascal Pineau
Nuclear Organization and Oncogenesis Unit, Institut National de Santé et de Recherche Médicale U579, Institut Pasteur, 75724 Paris Cedex 15, France
Proc Natl Acad Sci U S A 107:264-9. 2010..Thus, the use of synthetic inhibitors of miR-221 may prove to be a promising approach to liver cancer treatment...
Polymorphisms in antioxidant defence genes and susceptibility to hepatocellular carcinoma in a Moroccan populationSayeh Ezzikouri
Laboratoire des hépatites virales, Institut Pasteur du Maroc, 20360 Casablanca, Morocco
Free Radic Res 44:208-16. 2010..Furthermore, it is possible that cumulative defects in protection from oxidative stress may result in increased risk of liver cancer in the Moroccan population...
[Hepatitis B vaccination: a major player in the control of primary liver cancer]P Pineau
Inserm U579 Organisation nucléaire et oncogenèse, Institut Pasteur, 28, rue du Docteur Roux, 75724 Paris Cedex 15, France
Pathol Biol (Paris) 58:444-53. 2010..Finally, lack of early immunization of newborns in developing countries still represents a major limitation to the progresses against liver cancer...
Genomic stability prevails in North-African hepatocellular carcinomasP Pineau
Nuclear Organization and Oncogenesis Unit, INSERM U579, Pasteur Institute, Paris, France
Dig Liver Dis 39:671-7. 2007....
Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancerClaire Angélique Renard
Institut National de la Sante et de la Recherche Medicale U579, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris, France
Cancer Res 67:901-10. 2007..These results reveal an unsuspected role of Tbx3 as a mediator of beta-catenin activities on cell proliferation and survival and as an important player in liver tumorigenesis...
Studies of genetic defects in hepatocellular carcinoma: recent outcomes and new challengesP Pineau
J Hepatol 33:152-6. 2000
Effect of TT virus infection on hepatocellular carcinoma development: results of a Euro-Asian surveyP Pineau
Unite de Recombinaison et Expression Genetique, INSERM U163, Departement des Retrovirus, Institut Pasteur, Paris, France
J Infect Dis 181:1138-42. 2000..5% of the tumors. Taken together, these data suggest that TTV infection is unlikely to be associated with the induction or acceleration of the hepatocarcinogenic process in humans...
Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomasB Terris
Service d Anatomie Pathologique, Hopital Beaujon, Clichy, France
Oncogene 18:6583-8. 1999..The close association between increased beta-catenin protein stability and mutation indicates that immunohistochemistry may be a powerful method for the detection of the mutated protein in future clinical practice...
Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinomaP Pineau
Unité de Recombinaison and Expression Génétique, INSERM U163, Institut Pasteur, Paris, France
Oncogene 18:3127-34. 1999..These data strongly suggest the presence of at least three novel tumor suppressor loci on 8p in hepatocellular carcinoma...
[Hepatitis B virus and hepatocellular carcinoma]P Tiollais
Unité de Recombinaison et Expression Génétique INSERM U 163, Institut Pasteur, Paris
Bull Acad Natl Med 182:73-7; discussion 77-8. 1998..Study of transgenic mice have shown the liver specificity of the WHV action. In man, the liver oncogenesis is not explained. Studies are in progress to detect inactivation of tumor suppressor genes...
Extensive analysis of duplicated-inverted hepatitis B virus integrations in human hepatocellular carcinomaP Pineau
Unite de Recombinaison et Expression Genetique, INSERM U163, Institut Pasteur, Paris, France
J Gen Virol 79:591-600. 1998..The implications of our findings for the understanding of primary liver cancer development are discussed...
Comprehensive allelotyping of human hepatocellular carcinomaH Nagai
Unite de Recombinaison et Expression Genetique, INSERM U163, Institut Pasteur, Paris, France
Oncogene 14:2927-33. 1997..This first report of an extensive allelotypic analysis of HCC should help in identifying new genes whose loss of function contributes to the development of liver cancer...
Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridizationA Marchio
Unite de Recombinaison et Expression Genetique, INSERM U163, Institut Pasteur, Paris, France
Genes Chromosomes Cancer 18:59-65. 1997..These findings should lead to the characterization of new loci involved in liver cancer pathogenesis...
Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French casesM P Bralet
Départements, AP HP, Hopital Beaujon, Clichy Cedex, France
Hepatology 32:200-4. 2000..Etiologic factors are often unidentified, although presence of HBV infection in 21% suggests a direct oncogenic role of this virus...
Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patientsA Marchio
Unite de Recombinaison et Expression Genetique, INSERM U163, Institut Pasteur, Paris, France
Oncogene 19:3733-8. 2000..This region, which is also preferentially amplified in non fibrolamellar tumors (58%), may contain an essential proto-oncogene commonly implicated in liver carcinogenesis...
Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIPM Di Benedetto
Institut Cochin, Departement de Biologie Cellulaire, Paris, F 75014, France
Gene 380:127-36. 2006..High evolutionary conservation of ATIP amino-acid sequences suggests important biological roles for this new family of proteins in tumor suppression and/or brain function...
Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinomaM Di Benedetto
Institut Cochin, Departement de Biologie Cellulaire, Paris, F 75014 France
Mol Cell Endocrinol 252:207-15. 2006....
A universal primer set for PCR amplification of nuclear histone H4 genes from all animal speciesPascal Pineau
Unité d Organisation Nucléaire et Oncogénèse, INSERM U579, Institut Pasteur, Paris, France
Mol Biol Evol 22:582-8. 2005..The data indicate that the HIST2H4 amplimers are, thus, suitable for both DNA quality testing as well as species identification in the animal kingdom...
Homozygous deletions scanning in tumor cell lines detects previously unsuspected lociPascal Pineau
Unite de Recombinaison et Expression Genetique, INSERM, Département de Médecine Moléculaire, Institut Pasteur, Paris, France
Int J Cancer 106:216-23. 2003..Our data suggest that, beside allelotyping or transcriptome/proteome studies, extensive HD profiling represents a promising approach for the detection of hitherto not implicated signalling pathways of tumorigenesis...
Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesisPascal Pineau
Unite de Recombinaison et Expression Genetique, INSERM U163, Département de Médecine Moléculaire, Institut Pasteur, Paris, France
Hepatology 37:852-61. 2003..In conclusion, our data suggest that these genes may represent novel liver tumor suppressive targets. Additional tumorigenic pathways should be carefully considered in hepatocarcinogenesis...
Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinomaCheng Liao
State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, China
World J Gastroenterol 9:89-93. 2003..To find the point mutations meaningful for inactivation of liver-related putative tumor suppressor gene (LPTS) gene, a human novel liver-related putative tumor suppressor gene and telomerase inhibitor in hepatocellular carcinoma...
Identification of a hepatitis B virus genome in wild chimpanzees (Pan troglodytes schweinfurthi) from East Africa indicates a wide geographical dispersion among equatorial African primatesJean Pierre Vartanian
Unite de Retrovirologie Moleculaire, Institut Pasteur, Paris, France
J Virol 76:11155-8. 2002..An entire hepatitis B virus (HBV) genome was amplified and sequenced from samples taken from one animal. This indicates that HBV is distributed across the entire range of chimpanzee habitats...
Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisationA Marchio
Unite de Recombinaison et Expression Genetique, INSERM U163, Institut Pasteur, 75724 Paris, France
Mol Pathol 54:270-4. 2001..The aim of this study was to determine whether there is a genetic link between liver cell dysplasia and HCC that could support the role of dysplasia as a tumour precursor lesion...
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2Taewan Kim
Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, 2 Molecular, Cellular, and Developmental Biology Program, The Ohio State University, Columbus, OH 43210, USA
J Exp Med 208:875-83. 2011..Inhibition or overexpression of the miRNAs affects p53-regulated EMT by altering ZEB1 and ZEB2 expression. Our findings indicate that p53 can regulate EMT, and that p53-regulated miRNAs are critical mediators of p53-regulated EMT...
